ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Uveitis"

  • Abstract Number: 144 • 2020 Pediatric Rheumatology Symposium

    Failure of Methotrexate Monotherapy and Subsequent Response to Tumor Necrosis Factor Inhibitors in Pediatric Non-Infectious Uveitis

    Ashley Cooper1, Basak Can Ermerak 2, Katie Keck 3 and Erin Stahl 1, 1Children's Mercy Kansas City, Kansas City, 2University Hospitals Cleveland Medical Center, Cleveland, 3Palmetto Health USC Medical Group, Columbia

    Background/Purpose: Pediatric non-infectious uveitis is often treated with systemic immunomodulators in a step-wise fashion, with methotrexate (MTX) followed by tumor necrosis factor alpha inhibitors (TNFi)…
  • Abstract Number: 184 • 2020 Pediatric Rheumatology Symposium

    A Survey of Uveitis Knowledge Among Juvenile Arthritis Patients and Parents

    Ashley Cooper1, Elaine Flanagan 2, Tova Ronis 3, Baruch Goldberg 4, Ashley Sherman 1, Chelsey Smith 5 and Gary Holland 6 for the CARRA investigators, 1Children's Mercy Kansas City, Kansas City, 2Emory University, Atlanta, 3Children's National Hospital, Washington, 4UT Physicians, Houston, 5Children's Mercy Kansas City, Holden, 6

    Background/Purpose: Chronic anterior uveitis is a sight-threatening complication of juvenile idiopathic arthritis (JIA).  Prompt treatment to prevent complications requires regular screening and detection of uveitis…
  • Abstract Number: 077 • 2020 Pediatric Rheumatology Symposium

    Tubulointerstitial Nephritis and Uveitis (TINU): A Pediatric Case Series with Longitudinal Followup

    Deborah Stein 1, Elizabeth Benoit 1 and Mindy Lo1, 1Boston Children's Hospital, Boston

    Background/Purpose: Tubulointerstitial nephritis and uveitis (TINU) syndrome is an uncommon condition that is likely under-recognized. The ideal treatment of both renal and ophthalmologic disease activity…
  • Abstract Number: 101 • 2020 Pediatric Rheumatology Symposium

    Uveitis Treatment in the CARRA II Registry: Tumor Necrosis Factor-inhibitors and Beyond

    Mona Riskalla1, Fatima Barbar-Smiley 2, Michael Shyne 1 and Melissa Lerman 3, 1University of Minnesota, Minneapolis, Minnesota, 2Nationwide Children's Hospital, Columbus, Ohio, 3Philadelphia, Pennsylvania

    Background/Purpose: Uveitis associated with JIA (JIA-U) is the most common extra-articular complication of JIA. As JIA-U is associated with significant risk of visual loss and…
  • Abstract Number: 121 • 2020 Pediatric Rheumatology Symposium

    Evaluating the Relationship Between Juvenile Idiopathic Arthritis Disease Activity and Uveitis Activity: A Retrospective Analysis

    Emily Liebling1, Walter Faig 2, Nicholas Moore 1, Nahomy Ledesma Vicioso 3 and Melissa Lerman 4, 1Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 2Children's Hospital of Philadelphia, Philadelphia, 3Weill Cornell Medical College, New York, New York, 4Philadelphia, Pennsylvania

    Background/Purpose: JIA – associated uveitis (JIA-U) accounts for 20-40% of childhood noninfectious uveitis and affects 10-20% of patients with JIA. Its chronic course is often…
  • Abstract Number: 187 • 2019 ACR/ARP Annual Meeting

    Epidemiology of JIA-Associated Uveitis: Environmental Factors and Disease Characteristics of a JIA-Associated Uveitis Cohort

    Theresa Hennard 1, Najima Mwase 2, Amy Cassedy 3, Joseph McDonald 4, Virginia Utz 5 and Sheila Angeles-Han6, 1Division of Rheumatology, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, 5Division of Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cinicinnati

    Background/Purpose: JIA-associated uveitis (JIA-U) is the most prevalent extra-articular manifestation of JIA and the most common type of uveitis in children. To date, environmental factors…
  • Abstract Number: 247 • 2019 ACR/ARP Annual Meeting

    Health Literacy, Adherence, and Quality of Life of Uveitis Patients

    Claire Mueller 1 and Ghazala O'Keefe1, 1Emory University School of Medicine, Atlanta, GA

    Background/Purpose: To determine health literacy, medication adherence, and quality of life (QOL) of uveitis patients in order to understand how to deliver better and improved…
  • Abstract Number: 579 • 2019 ACR/ARP Annual Meeting

    Is There an Impact of Uveitis, Psoriasis and Inflammatory Bowel Disease on Musculoskeletal Disease Activity and Function in Axial Spondyloarthritis?

    Imke Redeker1, Johanna Callhoff 2, Falk Hoffmann 3, Hildrun Haibel 4, Joachim Sieper 4, Angela Zink 5 and Denis Poddubnyy 6, 1Charité – Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3Carl von Ossietzky University, Oldenburg, Germany, 4Charité Universitätsmedizin Berlin, Germany, Berlin, Germany, 5German Rheumatism Research Centre and Charité University medicine, Berlin, Germany, 6Charité - Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany, Berlin, Germany

    Background/Purpose: Uveitis, psoriasis and inflammatory bowel disease (IBD) are common in axial spondyloarthritis (axSpA) but data on their impact on activity of musculoskeletal manifestations and…
  • Abstract Number: 786 • 2019 ACR/ARP Annual Meeting

    Distinguishing S100 Proteins and Cytokine Levels Between Active and Inactive Uveitis in Children with Juvenile Idiopathic Arthritis

    Jackeline Rodriguez-Smith1, Virginia Utz 2, Sherry Thornton 1, Grant Schulert 1, Adam Kauffman 3, Alyssa Sproles 1, Najima Mwase 1, Theresa Hennard 4, Alexei A. Grom 1, Mekibib Altaye 5, Gary Holland 6 and Sheila Angeles-Han 7, 1Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Division of Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Eye Institute and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Division of Rheumatology, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 5Divison of Biostatistics and Epidemiology and Department of Pediatrics, University of Cincinnati, Cincinnati, OH, 6UCLA Stein Eye Institute and David Geffen School of Medicine at University of California, Los Angeles, Ca, Los Angeles, CA, 7Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cinicinnati

    Background/Purpose: Uveitis occurs in 10-20% of children with Juvenile Idiopathic Arthritis (JIA) and is typically asymptomatic. Ocular complications occur in 50% of children, (i.e. cataracts,…
  • Abstract Number: 935 • 2019 ACR/ARP Annual Meeting

    Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis Following 1 Year of Treatment with Certolizumab Pegol: 48-Week Interim Results from a 96-Week Open-Label Study

    Irene van der Horst-Bruinsma1, Rianne van Bentum 1, Frank D. Verbraak 1, Thomas Rath 2, James T. Rosenbaum 3, Maria Misterska-Skóra 4, Bengt Hoepken 5, Oscar Irvin-Sellers 6, Brenda VanLunen 7, Lars Bauer 5 and Martin Rudwaleit 8, 1Amsterdam University Medical Center, Amsterdam, Netherlands, 2St Franziskus-Hospital, Münster, Germany, 3Devers Eye Institute and Oregon Health & Science University, Portland, OR, 4Wrocław Medical University, Wrocław, Poland, 5UCB Pharma, Monheim am Rhein, Germany, 6UCB Pharma, Slough, UK, Slough, United Kingdom, 7UCB Pharma, Raleigh, NC, 8Klinikum Bielefeld, Charité Berlin, Gent University, Bielefeld, Germany

    Background/Purpose: Acute anterior uveitis (AAU), inflammation of the anterior uveal tract, is the most common extraarticular manifestation in patients (pts) with axial spondyloarthritis (axSpA), reported…
  • Abstract Number: 1246 • 2019 ACR/ARP Annual Meeting

    Using PROMIS Data to Assess Activity of Inflammatory Eye Disease

    Joshua Hedrick1, Rula Hajj-ali 2, Yuxuan Jin 3 and Sunil Srivastava 1, 1Cleveland Clinic, Cleveland, OH, 2Rheumatologic and Immunologic Disease/Cleveland Clinic, Cleveland, OH, 3Quantitative Health Science, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Diagnosing and managing patients with inflammatory eye disease (IED) requires close interdisciplinary care with rheumatologists adjusting systemic, potentially toxic, therapies based on exam findings…
  • Abstract Number: 1267 • 2019 ACR/ARP Annual Meeting

    Epidemology, Clinical Features and Relationship to Biological Therapy of Uveitis in Axial Spondyloarthritis: Single Center University Study

    Iñigo Gonzalez-Mazon1, Lara Sanchez-Bilbao 2, Javier Rueda-Gotor 3, DAVID MARTINEZ-LOPEZ 4, DIANA PRIETO- PENA 1, Mónica Calderón-Goercke 5, Jose Luis Martín-Varillas 2, Belén Atienza-Mateo 2, Miguel A Gonzalez-Gay 2 and Ricardo Blanco 2, 1Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 2Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, 3Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 4Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 5Hospital Marqués de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: Uveitis is one of the most frequent extra articular manifestation of spondyloarthritis (SpA). Biological therapy, especially monoclonal TNF inhibitors, are useful to prevent and…
  • Abstract Number: 1478 • 2019 ACR/ARP Annual Meeting

    Systematic Literature Review and Network Meta-Analysis Comparing Incidence of Uveitis and IBD in Axial Spondyloarthritis Patients Treated with Anti-TNF versus Anti-IL17A in Placebo Controlled Randomized Trials

    Damien Roche1, Martin Badard 1, Laurent Boyer 2, Pierre Lafforgue 1 and Thao Pham 1, 1Aix-Marseille University, CHU Marseille, department of Rheumatology, 13,000 Marseille, France, Marseille, France, 2Aix-Marseille University, EA 3279 Research Unit, 13,000 Marseille, France, Marseille, France

    Background/Purpose: Inflammatory bowel diseases (IBD) and anterior uveitis (AU) are frequent extra-articular features of axial spondyloarthritis (axSpA). Although effect of anti-TNF on IBD and AU…
  • Abstract Number: 2481 • 2019 ACR/ARP Annual Meeting

    Uveitis in 320 Patients with Psoriatic Arthritis. Epidemiology, Clinical Features and Biological Treatment: Study from a Single University Center

    Iñigo Gonzalez-Mazon1, Lara Sanchez-Bilbao 2, Natalia Palmou-Fontana 1, DAVID MARTINEZ-LOPEZ 3, Mónica Calderón-Goercke 4, DIANA PRIETO- PENA 1, Susana Armesto-Alonso 3, Miguel A Gonzalez-Gay 2 and Ricardo Blanco 2, 1Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 2Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, 3Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 4Hospital Marqués de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: Uveitis is an extra articular manifestation of psoriatic arthritis (PsA). Uveitis may be more chronic Biological therapy, especially monoclonal TNF inhibitors, are useful to…
  • Abstract Number: 2700 • 2019 ACR/ARP Annual Meeting

    Adalimumab Alone Is Superior to Adalimumab Plus Methotrexate in Juvenile Idiopathic Arthritis Associated Uveitis: Data from the ORCHIDEA Registry

    Gabriele Simonini1, Fabio Vittadello 2, Francesca Tirelli 3, Maria Elisabetta Zannin 2, Emanuela Del Giudice 4, Claudia Bracaglia 5, Serena Pastore 6, Mariolina Alessio 7, Angelo Ravelli 8, Francesco La Torre 9, Romina Gallizzi 10, Ilaria Maccora 11 and Francesco Zulian 2, 1Rheumatology Unit Anna Meyer Children's Hospital NEUROFARBA Dpt University of Florence, Firenze, Italy, 2Department of Woman and Child Health, University of Padua, Italy, Padova, Italy, 3Post Graduate School of Pediatrics, University of Florence, Florence, Italy, Firenze, Italy, 4Department of Pediatrics, Sapienza University, Rome, Italy, Roma, Italy, 5Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 6Institute for Maternal and Child Health IRCCS "Burlo Garofolo," Trieste, Italy, Trieste, Italy, 7University Hospital Federico II, Naples, Napoli, Italy, 8IRCCS Istituto Giannina Gaslini, Università degli Studi di Genova, Genova, Italy, 9Rheumatology Unit, Giovanni XXIII Children’s Hospital, Bari, Italy, Bari, Italy, 10Azienda Ospedaliera Universitaria Gaetano Martino, Messina, Messina, Italy, 11Post Graduate School of Pediatrics, University of Florence, Florence, Italy, Florence, Toscana, Italy

    Background/Purpose: To compare the efficacy and safety of Adalimumab alone (ADA) versus ADA in combination with Methotrexate (ADA-MTX) in an open-label, retrospective, comparative, multicentre cohort…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.